SK5942003A3 - Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain - Google Patents
Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain Download PDFInfo
- Publication number
- SK5942003A3 SK5942003A3 SK594-2003A SK5942003A SK5942003A3 SK 5942003 A3 SK5942003 A3 SK 5942003A3 SK 5942003 A SK5942003 A SK 5942003A SK 5942003 A3 SK5942003 A3 SK 5942003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- carbon atoms
- furan
- methyl
- alkyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10059864A DE10059864A1 (de) | 2000-11-30 | 2000-11-30 | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
| PCT/EP2001/013910 WO2002044171A1 (de) | 2000-11-30 | 2001-11-28 | Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK5942003A3 true SK5942003A3 (en) | 2003-11-04 |
Family
ID=7665508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK594-2003A SK5942003A3 (en) | 2000-11-30 | 2001-11-28 | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6797712B2 (es) |
| EP (1) | EP1341786B9 (es) |
| JP (1) | JP4340063B2 (es) |
| KR (1) | KR20030055334A (es) |
| CN (1) | CN1326854C (es) |
| AR (1) | AR035658A1 (es) |
| AT (1) | ATE418552T1 (es) |
| AU (2) | AU2073502A (es) |
| BR (1) | BR0115883A (es) |
| CA (1) | CA2430280A1 (es) |
| CY (1) | CY1108871T1 (es) |
| CZ (1) | CZ20031509A3 (es) |
| DE (2) | DE10059864A1 (es) |
| DK (1) | DK1341786T3 (es) |
| EC (1) | ECSDI034631S (es) |
| ES (1) | ES2320198T3 (es) |
| HK (1) | HK1059080A1 (es) |
| HU (1) | HUP0303041A3 (es) |
| IL (2) | IL156139A0 (es) |
| MX (1) | MXPA03004303A (es) |
| NO (1) | NO20032340L (es) |
| NZ (1) | NZ526554A (es) |
| PE (1) | PE20020599A1 (es) |
| PL (1) | PL362978A1 (es) |
| PT (1) | PT1341786E (es) |
| RU (1) | RU2003117703A (es) |
| SI (1) | SI1341786T1 (es) |
| SK (1) | SK5942003A3 (es) |
| WO (1) | WO2002044171A1 (es) |
| ZA (1) | ZA200305009B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794506B2 (en) * | 2000-07-21 | 2004-09-21 | Elan Pharmaceuticals, Inc. | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| DE10125145A1 (de) | 2001-05-22 | 2002-11-28 | Gruenenthal Gmbh | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| DE10306203A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US10144736B2 (en) * | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
| CU20180011A7 (es) | 2015-03-04 | 2018-06-05 | Gilead Sciences Inc | Composiciones farmacéuticas que comprenden compuestos derivados de diaminopirido (3,2-d) como moduladores de receptor de tipo toll |
| CA3035346A1 (en) | 2016-09-02 | 2018-03-08 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
| ES2826748T3 (es) | 2016-09-02 | 2021-05-19 | Gilead Sciences Inc | Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll |
| TWI751516B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TWI751517B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
| CN115382297B (zh) * | 2022-04-12 | 2023-10-31 | 江阴市华思诚无纺布有限公司 | 熔体直纺双组分pet纺粘液体过滤材料及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69739048D1 (de) * | 1996-06-28 | 2008-11-27 | Univ Southern California | Verfahren zur synthese von aminen und aminosäuren mit organoborverbindungen |
| US6441237B1 (en) | 1999-02-20 | 2002-08-27 | Boehringer Ingelheim Pharma Kg | Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines |
| DE19907385A1 (de) * | 1999-02-20 | 2000-08-24 | Boehringer Ingelheim Pharma | Neue substituierte 3-Phenoxy- und 3-Phenylalkyloxy-2-phenyl-propylamine |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
-
2000
- 2000-11-30 DE DE10059864A patent/DE10059864A1/de not_active Ceased
-
2001
- 2001-11-26 AR ARP010105486A patent/AR035658A1/es not_active Application Discontinuation
- 2001-11-28 ES ES01998547T patent/ES2320198T3/es not_active Expired - Lifetime
- 2001-11-28 CZ CZ20031509A patent/CZ20031509A3/cs unknown
- 2001-11-28 PL PL01362978A patent/PL362978A1/xx not_active Application Discontinuation
- 2001-11-28 SI SI200130905T patent/SI1341786T1/sl unknown
- 2001-11-28 CN CNB018197876A patent/CN1326854C/zh not_active Expired - Fee Related
- 2001-11-28 DK DK01998547T patent/DK1341786T3/da active
- 2001-11-28 BR BR0115883-0A patent/BR0115883A/pt not_active IP Right Cessation
- 2001-11-28 WO PCT/EP2001/013910 patent/WO2002044171A1/de active IP Right Grant
- 2001-11-28 AT AT01998547T patent/ATE418552T1/de active
- 2001-11-28 RU RU2003117703/04A patent/RU2003117703A/ru not_active Application Discontinuation
- 2001-11-28 CA CA002430280A patent/CA2430280A1/en not_active Abandoned
- 2001-11-28 PT PT01998547T patent/PT1341786E/pt unknown
- 2001-11-28 HU HU0303041A patent/HUP0303041A3/hu unknown
- 2001-11-28 KR KR10-2003-7007315A patent/KR20030055334A/ko not_active Application Discontinuation
- 2001-11-28 AU AU2073502A patent/AU2073502A/xx active Pending
- 2001-11-28 JP JP2002546541A patent/JP4340063B2/ja not_active Expired - Fee Related
- 2001-11-28 DE DE50114605T patent/DE50114605D1/de not_active Expired - Lifetime
- 2001-11-28 AU AU2002220735A patent/AU2002220735B2/en not_active Ceased
- 2001-11-28 MX MXPA03004303A patent/MXPA03004303A/es active IP Right Grant
- 2001-11-28 NZ NZ526554A patent/NZ526554A/en unknown
- 2001-11-28 EP EP01998547A patent/EP1341786B9/de not_active Expired - Lifetime
- 2001-11-28 IL IL15613901A patent/IL156139A0/xx active IP Right Grant
- 2001-11-28 SK SK594-2003A patent/SK5942003A3/sk not_active Application Discontinuation
- 2001-11-29 PE PE2001001195A patent/PE20020599A1/es not_active Application Discontinuation
-
2003
- 2003-05-23 NO NO20032340A patent/NO20032340L/no not_active Application Discontinuation
- 2003-05-27 IL IL156139A patent/IL156139A/en not_active IP Right Cessation
- 2003-05-29 EC EC2003004631F patent/ECSDI034631S/es unknown
- 2003-05-30 US US10/448,323 patent/US6797712B2/en not_active Expired - Fee Related
- 2003-06-26 ZA ZA200305009A patent/ZA200305009B/en unknown
-
2004
- 2004-03-09 HK HK04101704.1A patent/HK1059080A1/xx not_active IP Right Cessation
-
2009
- 2009-03-12 CY CY20091100279T patent/CY1108871T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2291065C (en) | Raf kinase inhibitors | |
| CA2988147C (en) | 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders | |
| AU2009273932B2 (en) | Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds | |
| SK5942003A3 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
| EP1444228B1 (en) | Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors | |
| US20090270408A1 (en) | Amide derivatives as positive allosteric modulators and methods of use thereof | |
| JP2007525482A (ja) | イオンチャネルリガンドとしてのアミド化合物およびその使用 | |
| MX2011001090A (es) | Compuestos de inhibidor de desacetilasa de histona de cicloalquilideno y heterocicloalquilideno. | |
| JP2008501691A (ja) | 化学化合物および炎症性疾患を処置するためにその化学化合物を含む薬学的組成物 | |
| CN102639135A (zh) | 作为bace抑制剂的亚氨基噻二嗪二氧化物化合物、组合物和它们的用途 | |
| JP2011507894A (ja) | プロリルヒドロキシラーゼ阻害剤 | |
| US9409864B2 (en) | Sulfonamide TRPA1 receptor antagonists | |
| US8383657B2 (en) | Thiazolylidine urea and amide derivatives and methods of use thereof | |
| KR20040086428A (ko) | 피롤로피리미딘 유도체 | |
| US5648486A (en) | Compounds and methods for the treatment of inflammatory and immune disorders | |
| WO2012038904A1 (fr) | Derives de nicotinamide, leur preparation et leur application en therapeutique | |
| CA3015914A1 (en) | Thiazolidinone compounds and use thereof | |
| JP3878128B2 (ja) | チエノピロリジノン | |
| US9776991B2 (en) | Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase | |
| AU2001298052A1 (en) | Protease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |